遺伝性卵巣がんのリスク,バイオマーカー,精密治療の再定義: レビュー

Ambika Nand Jha¹, Varsha Ratan Gaikwad², Ashok Kumar Gupta¹

¹School of Pharmacy, Sharda University, Greater Noida, Uttar Pradesh 201306, India.

ACS omega

|September 2, 2025

まとめ

遺伝性卵巣がん (HOC) の理解は,遺伝的感受性,特にBRCA1/BRCA2変異を含む. リスク評価,予防,PARP阻害剤の進歩は,この致命的な婦人科悪性腫瘍の改善を可能にします.

科学分野:

腫瘍学
遺伝学
流行病学について

背景:

遺伝性卵巣がん (HOC) は,しばしば遅れて診断される重大な健康上の負担です.
BRCA1およびBRCA2遺伝子の病原性生殖系変異は,HOCの主要な原動力である.
これらの変異はDNA修復を阻害しゲノム不安定と癌のリスクを増大させます

研究の目的:

遺伝性卵巣がんの進化を振り返る
薬学流行病学,リスク評価,化学予防,標的治療に重点を置く
HOCの臨床意思決定を洗練し精密医療を進める

主な方法:

遺伝性卵巣がんに関する文献のレビュー
リスク評価モデルの分析 (BRCAPRO,BOADICEA)
予防戦略 (RRSO,化学予防) と標的療法 (PARP阻害剤) の評価

主要な成果:

遺伝子スクリーニングはHOCの早期発見と予防を容易にする.
危険を軽減するサルピングオオフォレクトミーと化学予防はOCの発生率を減らす.
PARP阻害剤は,HOCの無進行生存率の有意な改善を示しています.

結論:

精密医療のアプローチは HOCの管理に革命を起こしています
PARP阻害剤のような標的治療は,同種の再結合欠乏性腫瘍に不可欠です.
遺伝性卵巣がんの患者の治療結果を改善することを目指しています.

さらに関連する動画

13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K

10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

関連する概念動画

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

5.1K

01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

174

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

174

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...